President and CEO, PATH
Professor of Chemistry, Harvard University
CEO, Aires Pharmaceuticals and Palkion
Partner, Emerging Companies and Life Sciences, Cooley LLP
Co-Founder and CEO, DNAnexus
Chief Scientist, Mimecast
Professor, Laboratory of Genetics, Salk Institute
Professor of Innovation at The University of Texas at Austin
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Bind Biosciences, My IPO Prediction, and Brain Overload at MassOpps | Rebecca Zacks | 11/09/07 | Boston | |
| Boston’s New Generation of University Spinoffs | Rebecca Zacks | 09/06/07 | Boston | |
| Boston’s New Generation of University Spinoffs: The List | Rebecca Zacks | 09/06/07 | Boston | |
| Page 2 of 2 | « previous page | |||